LOTUS PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280 TWD | -0.36% |
|
-6.98% | +2.94% |
Chart calendar Lotus Pharmaceutical Co., Ltd.
e07d6735ba0e1ec5671061ae42a.evYq29ioeKxcgfeX_RUCARomYDu7qUPpynckYQJOgMo.Drt7l5TwCsgMsrKnvCJ1TTdQWX6K3C2gixRFI0gHzJVOj3yMoZ0C9DTJtg~5550125a4ea3bafb36c75e78d84a83e5
Upcoming events on Lotus Pharmaceutical Co., Ltd.
Past events on Lotus Pharmaceutical Co., Ltd.
| 09/05/2024 | Q1 2024 Earnings Release |
| 09/04/2024 11:30 am | Biotechnology and Medical Care Industry Investor Conference |
| 28/03/2024 01:00 pm | Mega Securities Investor Conference |
| 19/03/2024 01:00 pm | UBS Securities Investor Conference |
| 19/03/2024 11:30 am | Q4 2023 Earnings Call |
| 14/03/2024 08:00 pm | Q4 2023 Earnings Release |
| 08/03/2024 02:31 pm | February 2024 Sales and Revenue Release |
| 07/02/2024 01:02 pm | January 2024 Sales and Revenue Release |
| 10/01/2024 04:30 pm | December 2023 Sales and Revenue Release |
| 14/11/2023 02:30 pm | Q3 2023 Earnings Call |
| 10/11/2023 | October 2023 Sales and Revenue Release |
| 09/11/2023 | Q3 2023 Earnings Release |
| 16/10/2023 06:30 am | JP Morgan Global Healthcare Shanghai Conference |
| 11/10/2023 02:25 pm | September 2023 Sales and Revenue Release |
| 12/09/2023 08:48 am | August 2023 Sales and Revenue Release |
| 15/08/2023 01:30 pm | KGI Securities Investor Conference |
| 15/08/2023 11:30 am | Q2 2023 Earnings Call |
| 11/08/2023 01:36 pm | Q2 2023 Earnings Release |
| 10/08/2023 02:30 pm | July 2023 Sales and Revenue Release |
| 19/07/2023 11:30 am | Yuanta Securities Investor Conference |
Past dividends on Lotus Pharmaceutical Co., Ltd.
| 05/07/2023 | Other Dividend 3.459921 TWD |
| 04/08/2022 | Other Dividend 1.931215 TWD |
| 07/07/2021 | Annual 0.35 TWD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 9 175 9 014 1.78% | 10 729 10 686 0.4% | 12 649 12 773 -0.97% | 14 633 14 393 1.67% | 16 958 17 025 -0.39% | 18 861 |
|
EBITDA Million TWD | Released Forecast Spread | 1 700 1 965 -13.49% | 2 322 2 384 -2.59% | 3 054 3 016 1.26% | 5 048 4 930 2.4% | 6 114 6 401 -4.48% | 7 352 |
|
EBIT Million TWD | Released Forecast Spread | 1 113 1 451 -23.3% | 1 613 1 621 -0.51% | 2 295 2 383 -3.67% | 4 111 4 164 -1.28% | 4 903 5 407 -9.33% | 6 432 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 876 1 155 -24.12% | 1 304 1 295 0.71% | 1 870 1 949 -4.03% | 3 940 3 977 -0.93% | 5 103 5 139 -0.71% | 6 203 |
|
Net income Million TWD | Released Forecast Spread | 663 877 -24.42% | 1 030 1 019 1.09% | 1 403 1 456 -3.61% | 3 021 3 099 -2.52% | 4 106 4 090 0.37% | 4 825 |
|
EPS TWD | Released Forecast Spread | 2,74 3,61 -24.1% | 4,22 4,20 0.6% | 5,47 5,56 -1.62% | 11,6 12,0 -3.14% | 15,7 15,6 1.05% | 18,6 |
| Announcement Date | 19/03/20 | 26/03/21 | 16/03/22 | 14/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 3 161 2 998 5.46% | 2 910 2 954 -1.47% | 5 389 5 224 3.15% | 3 172 2 971 6.76% | 4 524 4 058 11.49% | 4 442 4 205 5.62% | 4 573 4 498 1.67% | 3 419 3 464 -1.28% | 4 198 4 237 -0.92% | 5 092 | 5 295 | 4 294 | 4 951 | 4 911 |
|
EBITDA Million TWD | Released Forecast Spread | 833 814 2.27% | 730 782 -6.6% | 2 881 1 076 167.76% | 1 964 936 109.88% | 1 908 1 711 11.52% | 1 775 1 739 2.05% | 469 875 -46.34% | 1 572 1 352 16.28% | 1 979 | 2 126 | 982 | |||
|
EBIT Million TWD | Released Forecast Spread | 624 591 5.5% | 490 494 -0.7% | 2 641 2 176 21.38% | 356 411 -13.25% | 1 664 1 327 25.36% | 1 614 1 445 11.65% | 1 482 1 612 -8.05% | 143 696 -79.4% | 1 256 1 455 -13.73% | 1 955 | 2 110 | 1 028 | 1 875 | 1 836 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 589 504 16.74% | 427 424 0.58% | 2 630 2 088 25.96% | 295 333 -11.47% | 1 505 1 056 42.48% | 1 524 1 378 10.55% | 1 566 1 574 -0.51% | 508 556 -8.64% | 1 306 1 390 -6.03% | 1 894 | 2 076 | 997 | 1 792 | 1 755 |
|
Net income Million TWD | Released Forecast Spread | 446 381 17.03% | 328 318 3.04% | 2 079 1 554 33.83% | 168 247 -32.01% | 1 194 803 48.73% | 1 266 1 054 20.05% | 1 246 1 225 1.73% | 400 415 -3.57% | 1 036 1 086 -4.56% | 1 467 | 1 590 | 732 | 1 390 | 1 354 |
|
EPS TWD | Released Forecast Spread | 1,71 1,45 17.77% | 1,25 1,22 2.74% | 7,93 5,94 33.45% | 0,63 0,94 -32.98% | 4,55 3,07 48.45% | 4,84 4,03 20.22% | 4,76 4,69 1.6% | 1,53 1,46 4.51% | 3,94 4,14 -4.92% | 5,59 | 6,05 | 2,78 | 5,28 | 5,14 |
| Announcement Date | 13/05/22 | 11/08/22 | 10/11/22 | 14/03/23 | 15/05/23 | 11/08/23 | 10/11/23 | 15/03/24 | 11/05/24 | - | - | - | - | - |
More events
Past sector events for Lotus Pharmaceutical Co., Ltd.
| Today | BLUE JET HEALTHCARE LIMITED: Q4 2024 Earnings Release |
| Today | AUROBINDO PHARMA: Q4 2024 Earnings Release |
| Today | DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 24/05/2024 | TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 24/05/2024 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release |
| 23/05/2024 08:17 pm | ORCHID PHARMA LIMITED: Q4 2024 Earnings Release |
| 23/05/2024 | SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release |
| 22/05/2024 05:36 pm | GLAND PHARMA LIMITED: Q4 2024 Earnings Release |
| 21/05/2024 04:27 pm | ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
| 21/05/2024 02:30 am | TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1795 Stock
- Calendar Lotus Pharmaceutical Co., Ltd.
